A Dark Vector Cognition product

Item 1. Financial Statements

147K characters. Original on sec.gov ·

Item 1. Financial Statements

The 44 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

STATEMENT OF EARNINGS (LOSS) (UNAUDITED)Three months ended September 30Nine months ended September 30
(In millions, per-share amounts in dollars)2023202220232022
Sales of equipment$6,939$5,731$18,915$15,605
Sales of services9,5658,09527,13623,493
Insurance revenues (Note 13)8426452,4802,175
Total revenues (Note 8)17,34614,47048,53141,272
Cost of equipment sold7,0656,48819,61017,165
Cost of services sold5,8395,04616,38614,668
Selling, general and administrative expenses2,1711,9666,6716,509
Separation costs (Note 20)227171658419
Research and development4714261,3561,269
Interest and other financial charges2863748221,130
Insurance losses, annuity benefits and other costs (Note 13)7105042,1291,794
Non-operating benefit cost (income)(396)(96)(1,183)(302)
Total costs and expenses16,37314,88046,44942,650
Other income (loss) (Note 19)(673)1786,100(1,000)
Earnings (loss) from continuing operations before income taxes300(232)8,182(2,378)
Benefit (provision) for income taxes (Note 16)(138)(13)(741)(203)
Earnings (loss) from continuing operations161(245)7,440(2,581)
Earnings (loss) from discontinued operations, net of taxes (Note 2)173409412775
Net earnings (loss)3351657,852(1,806)
Less net earnings (loss) attributable to noncontrolling interests(14)4(37)51
Net earnings (loss) attributable to the Company3481617,889(1,857)
Preferred stock dividends and other(91)(73)(295)(192)
Net earnings (loss) attributable to GE common shareholders$258$88$7,594$(2,049)
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations$161$(245)$7,440$(2,581)
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations(14)(2)(37)19
Earnings (loss) from continuing operations attributable to the Company175(243)7,478(2,600)
Preferred stock dividends and other(91)(73)(295)(192)
Earnings (loss) from continuing operations attributable
to GE common shareholders84(316)7,183(2,792)
Earnings (loss) from discontinued operations attributable
to GE common shareholders173403411743
Net earnings (loss) attributable to GE common shareholders$258$88$7,594$(2,049)
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share$0.08$(0.29)$6.54$(2.54)
Basic earnings (loss) per share$0.08$(0.29)$6.60$(2.54)
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share$0.23$0.08$6.91$(1.86)
Basic earnings (loss) per share$0.24$0.08$6.98$(1.86)

2023 3Q FORM 10-Q 19

STATEMENT OF FINANCIAL POSITION (UNAUDITED)
(In millions)September 30, 2023December 31, 2022
Cash, cash equivalents and restricted cash$13,127$15,810
Investment securities (Note 3)7,0547,609
Current receivables (Note 4)14,54614,831
Inventories, including deferred inventory costs (Note 5)17,02014,891
Current contract assets (Note 9)1,8752,467
All other current assets (Note 10)1,4381,400
Assets of businesses held for sale (Note 2)1,3751,374
Current assets56,43458,384
Investment securities (Note 3)35,52836,027
Property, plant and equipment – net (Note 6)12,20312,192
Goodwill (Note 7)13,17712,999
Other intangible assets – net (Note 7)5,7906,105
Contract and other deferred assets (Note 9)5,4275,776
All other assets (Note 10)16,30715,477
Deferred income taxes (Note 16)10,23510,001
Assets of discontinued operations (Note 2)1,56031,890
Total assets$156,662$188,851
Short-term borrowings (Note 11)$1,334$3,739
Accounts payable and equipment project payables (Note 12)15,78515,399
Progress collections and deferred income (Note 9)17,18516,216
All other current liabilities (Note 15)12,02612,130
Liabilities of businesses held for sale (Note 2)1,8351,944
Current liabilities48,16449,428
Deferred income (Note 9)1,3371,409
Long-term borrowings (Note 11)19,48820,320
Insurance liabilities and annuity benefits (Note 13)35,83236,845
Non-current compensation and benefits9,71810,400
All other liabilities (Note 15)11,17711,063
Liabilities of discontinued operations (Note 2)1,11224,474
Total liabilities126,830153,938
Preferred stock (Note 17)—6
Common stock (Note 17)1515
Accumulated other comprehensive income (loss) – net attributable to GE (Note 17)(3,351)(2,272)
Other capital27,22934,173
Retained earnings85,01782,983
Less common stock held in treasury(80,244)(81,209)
Total GE shareholders’ equity28,66533,696
Noncontrolling interests1,1671,216
Total equity29,83234,912
Total liabilities and equity$156,662$188,851

2023 3Q FORM 10-Q 20

STATEMENT OF CASH FLOWS (UNAUDITED)Nine months ended September 30
(In millions)20232022
Net earnings (loss)$7,852$(1,806)
(Earnings) loss from discontinued operations activities(412)(775)
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities
Depreciation and amortization of property, plant and equipment1,0971,130
Amortization of intangible assets (Note 7)4481,193
(Gains) losses on purchases and sales of business interests (Note 19)(103)(42)
(Gains) losses on retained and sold ownership interests and other equity securities(5,181)2,145
Principal pension plans cost (Note 14)(834)269
Principal pension plans employer contributions(156)(152)
Other postretirement benefit plans (net)(496)(617)
Provision (benefit) for income taxes741203
Cash recovered (paid) during the year for income taxes(806)(295)
Changes in operating working capital:
Decrease (increase) in current receivables120(2,583)
Decrease (increase) in inventories, including deferred inventory costs(2,220)(2,226)
Decrease (increase) in current contract assets775934
Increase (decrease) in accounts payable and equipment project payables3941,697
Increase (decrease) in progress collections and current deferred income9491,227
Financial services derivatives net collateral/settlement3(154)
All other operating activities180232
Cash from (used for) operating activities – continuing operations2,354379
Cash from (used for) operating activities – discontinued operations(315)1,038
Cash from (used for) operating activities2,0381,417
Additions to property, plant and equipment and internal-use software(1,065)(801)
Dispositions of property, plant and equipment77157
Proceeds from principal business dispositions—15
Net cash from (payments for) principal businesses purchased(365)(30)
Dispositions of retained ownership interests7,0374,071
Net (purchases) dispositions of insurance investment securities(1,240)(1,189)
All other investing activities906(150)
Cash from (used for) investing activities – continuing operations5,3512,073
Cash from (used for) investing activities – discontinued operations(3,058)(481)
Cash from (used for) investing activities2,2931,592
Net increase (decrease) in borrowings (maturities of 90 days or less)(35)66
Newly issued debt (maturities longer than 90 days)10—
Repayments and other debt reductions (maturities longer than 90 days)(3,230)(3,178)
Dividends paid to shareholders(501)(455)
Redemption of GE preferred stock(5,795)(104)
Purchases of GE common stock for treasury(945)(688)
All other financing activities278(679)
Cash from (used for) financing activities – continuing operations(10,217)(5,038)
Cash from (used for) financing activities – discontinued operations1,999(89)
Cash from (used for) financing activities(8,218)(5,127)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash(91)(623)
Increase (decrease) in cash, cash equivalents and restricted cash(3,978)(2,741)
Cash, cash equivalents and restricted cash at beginning of year19,09216,859
Cash, cash equivalents and restricted cash at September 3015,11414,118
Less cash, cash equivalents and restricted cash of discontinued operations at September 301,2441,573
Cash, cash equivalents and restricted cash of continuing operations at September 30$13,869$12,545

2023 3Q FORM 10-Q 21

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)Three months ended September 30Nine months ended September 30
(In millions)2023202220232022
Net earnings (loss)$335$165$7,852$(1,806)
Less: net earnings (loss) attributable to noncontrolling interests(14)4(37)51
Net earnings (loss) attributable to the Company$348$161$7,889$(1,857)
Currency translation adjustments(396)(874)2,085(1,815)
Benefit plans(188)259(2,680)788
Investment securities and cash flow hedges(1,379)(1,904)(1,147)(7,597)
Long-duration insurance contracts(a)2,1872,0366608,949
Less: other comprehensive income (loss) attributable to noncontrolling interests1(4)(3)—
Other comprehensive income (loss) attributable to the Company$223$(479)$(1,079)$324
Comprehensive income (loss)$559$(318)$6,770$(1,482)
Less: comprehensive income (loss) attributable to noncontrolling interests(12)—(40)51
Comprehensive income (loss) attributable to the Company$571$(318)$6,810$(1,533)

(a) Represents the net after-tax change in future policy benefit reserves and related reinsurance recoverables from updating the discount rate. See Notes 1 and 13 for further information.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)Three months ended September 30Nine months ended September 30
(In millions)2023202220232022
Preferred stock issued(a)$—$6$—$6
Common stock issued$15$15$15$15
Beginning balance(3,573)(4,057)(2,272)(4,860)
Currency translation adjustments(397)(871)2,086(1,813)
Benefit plans(188)259(2,678)786
Investment securities and cash flow hedges(1,379)(1,904)(1,147)(7,597)
Long-duration insurance contracts2,1872,0366608,949
Accumulated other comprehensive income (loss)$(3,351)$(4,536)$(3,351)$(4,536)
Beginning balance30,42634,38234,17334,691
Gains (losses) on treasury stock dispositions(491)(115)(1,503)(608)
Stock-based compensation8790257270
Other changes(a)(2,793)(103)(5,698)(99)
Other capital$27,229$34,254$27,229$34,254
Beginning balance84,84880,97282,98383,286
Net earnings (loss) attributable to the Company3481617,889(1,857)
Dividends and other transactions with shareholders(b)(180)(161)(5,856)(457)
Retained earnings$85,017$80,971$85,017$80,971
Beginning balance(80,524)(80,883)(81,209)(81,093)
Purchases(315)(317)(953)(701)
Dispositions5951501,918745
Common stock held in treasury$(80,244)$(81,049)$(80,244)$(81,049)
GE shareholders' equity balance28,66529,66028,66529,660
Noncontrolling interests balance1,1671,2781,1671,278
Total equity balance at September 30$29,832$30,938$29,832$30,938

(a) Included decreases of $2,795 million and $5,795 million, substantially all in Other capital related to our redemption of GE preferred stock in the three and nine months ended September 30, 2023, respectively.

(b) Included a $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.

2023 3Q FORM 10-Q 22

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event.

In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.

We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.

The accompanying consolidated financial statements and notes are unaudited. The results reported in these financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the financial statements, notes and significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2022 and revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the fourth quarter of 2022, we signed a binding agreement to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). We expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the fourth quarter of 2023. Closing the transaction is expected to result in a significant gain.

In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, Electric Insurance Company, domiciled in Massachusetts, with assets of $533 million and liabilities of $351 million as of September 30, 2023, into held for sale. In the third quarter of 2023, we signed a binding agreement to sell this business and expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the first half of 2024. In connection with the expected sale, for the nine months ended September 30, 2023, we recorded a loss of $109 million in Other income (loss) in our Statement of Earnings (Loss).

ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALESeptember 30, 2023December 31, 2022
Current receivables, inventories and contract assets$539$495
Non-current captive insurance investment securities555554
Property, plant and equipment and intangible assets - net235232
Valuation allowance on disposal group classified as held for sale(126)(17)
All other assets172111
Assets of businesses held for sale$1,375$1,374
Progress collections and deferred income$1,083$1,127
Insurance liabilities and annuity benefits357358
Accounts payable, equipment project payables and other current liabilities338371
All other liabilities5887
Liabilities of businesses held for sale$1,835$1,944

DISCONTINUED OPERATIONS primarily comprise our former GE HealthCare business, our mortgage portfolio in Poland (Bank BPH), our GE Capital Aviation Services (GECAS) business, and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.

GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business (the Separation), into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation are reported in GE's consolidated financial statements as discontinued operations.

2023 3Q FORM 10-Q 23

We have continuing involvement with GE HealthCare primarily through a transition services agreement, through which GE and GE HealthCare continue to provide certain services to each other for a period of time following the Separation, and a trademark licensing agreement. For the nine months ended September 30, 2023, we collected net cash of $715 million related to these activities.

Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded a charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH as of September 30, 2023 was $2,522 million. In order to maintain appropriate regulatory capital levels, during the nine months ended September 30, 2023, we made previously reported non-cash capital contributions in the form of intercompany loan forgiveness of $1,797 million; no incremental cash contributions from GE were required in connection with the second quarter charge. For further information about the recent actions and other factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH, refer to our disclosures about Bank BPH in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 and other prior filings. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH.

The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. Earnings (loss) from discontinued operations included zero and $1,189 million in pre-tax charges for the three and nine months ended September 30, 2023, and $128 million and $562 million in pre-tax charges for the three and nine months ended September 30, 2022, respectively, primarily related to the ongoing borrower litigation. At September 30, 2023, the total portfolio had a carrying value of zero, net of a valuation allowance.

GECAS/AerCap. We have continuing involvement with AerCap, primarily through our ownership interest, ongoing sales or leases of products and services, and transition services that we provide to AerCap. For the nine months ended September 30, 2023, we had direct and indirect sales of $122 million to AerCap, primarily related to engine services and sales, and purchases of $175 million from AerCap, primarily related to engine leases. We paid net cash of $157 million to AerCap related to this activity.

20232022
RESULTS OF DISCONTINUED OPERATIONS Three months ended September 30GE HealthCareBank BPH & OtherTotalGE HealthCareBank BPH & OtherTotal
Total revenues$—$—$—$4,612$—$4,612
Cost of equipment and services sold———(2,838)—(2,838)
Other income, costs and expenses(34)(5)(39)(1,185)(153)(1,338)
Earnings (loss) of discontinued operations before income taxes(34)(5)(39)589(153)436
Benefit (provision) for income taxes222(12)210(95)(22)(116)
Earnings (loss) of discontinued operations, net of taxes188(17)171494(174)320
Gain (loss) on disposal before income taxes—22———
Benefit (provision) for income taxes————9090
Gain (loss) on disposal, net of taxes—22—9090
Earnings (loss) from discontinued operations, net of taxes$188$(15)$173$494$(85)$409
20232022
RESULTS OF DISCONTINUED OPERATIONS Nine months ended September 30GE HealthCareBank BPH & OtherTotalGE HealthCareBank BPH & OtherTotal
Total revenues$—$—$—$13,491$—$13,491
Cost of equipment and services sold———(8,237)—(8,237)
Other income, costs and expenses(54)(1,246)(1,300)(3,523)(608)(4,132)
Earnings (loss) of discontinued operations before income taxes(54)(1,246)(1,300)1,731(608)1,123
Benefit (provision) for income taxes1,708(2)1,706(387)(36)(424)
Earnings (loss) of discontinued operations, net of taxes1,654(1,248)4061,344(644)699
Gain (loss) on disposal before income taxes—66—(30)(30)
Benefit (provision) for income taxes———1295107
Gain (loss) on disposal, net of taxes—66126476
—
Earnings (loss) from discontinued operations, net of taxes$1,654$(1,242)$412$1,356$(580)$775

2023 3Q FORM 10-Q 24

The tax benefit for the three and nine months ended September 30, 2023 for GE HealthCare relates to retroactive 2023 IRS guidance concerning foreign tax credits and accounting method changes and completion of the 2022 U.S. federal tax return. The tax benefit for the nine months ended September 30, 2023 also includes preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain.

ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONSSeptember 30, 2023December 31, 2022
Cash, cash equivalents and restricted cash$1,244$2,627
Current receivables113,361
Inventories, including deferred inventory costs—2,512
Goodwill—12,799
Other intangible assets - net—1,520
Contract and other deferred assets—854
Financing receivables held for sale (Polish mortgage portfolio)(a)—1,200
Property, plant and equipment - net612,379
All other assets2022,109
Deferred income taxes412,528
Assets of discontinued operations$1,560$31,890
Accounts payable and equipment project payables$69$3,487
Progress collections and deferred income—2,499
Long-term borrowings—8,273
Non-current compensation and benefits355,658
All other liabilities(a)1,0074,556
Liabilities of discontinued operations$1,112$24,474

(a) Included $1,913 million and $848 million of valuation allowances against Financing receivables held for sale, of which $1,678 million and $611 million related to estimated borrower litigation losses, and $844 million and $748 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of September 30, 2023 and December 31, 2022, respectively. Accordingly, total estimated losses related to borrower litigation were $2,522 million and $1,359 million as of September 30, 2023 and December 31, 2022, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of September 30, 2023.

NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We manage the investments in our run-off insurance operations under strict investment guidelines, including limitations on asset class concentration, single issuer exposures, asset-liability duration variances, and other factors to meet credit quality, yield, liquidity and diversification requirements associated with servicing our insurance liabilities under reasonable circumstances. This process includes consideration of various asset allocation strategies and incorporates information from several external investment advisors to improve our investment yield subject to maintaining our ability to satisfy insurance liabilities when due, as well as considering our risk-based capital requirements, regulatory constraints, and tolerance for surplus volatility. Asset allocation planning is a dynamic process that considers changes in market conditions, risk appetite, liquidity needs and other factors, which are reviewed on a periodic basis by our investment team. Our investment in GE HealthCare comprised 61.6 million shares (approximately 13.5% ownership interest) at September 30, 2023. Our investment in AerCap comprised 30.9 million ordinary shares (approximately 14.5% ownership interest) at September 30, 2023 and an AerCap senior note, for which we have adopted the fair value option. We sold our remaining shares in Baker Hughes during the first quarter of 2023. Our GE HealthCare and AerCap investments are recorded as Equity securities with readily determinable fair values (RDFV). Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities.

September 30, 2023December 31, 2022
Amortized costGross unrealized gainsGross unrealized lossesEstimated fair valueAmortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Equity (GE HealthCare)$—$—$—$4,190$—$—$—$—
Equity and note (AerCap)———2,864———7,403
Equity (Baker Hughes)———————207
Current investment securities$—$—$—$7,054$—$—$—$7,609
Debt
U.S. corporate$27,539$280$(2,947)$24,872$26,921$675$(2,164)$25,432
Non-U.S. corporate2,51310(381)2,1412,54818(300)2,266
State and municipal2,75918(301)2,4752,89866(241)2,722
Mortgage and asset-backed4,80612(361)4,4574,44221(290)4,173
Government and agencies1,4441(177)1,2671,1722(147)1,026
Other equity315——315408——408
Non-current investment securities$39,376$320$(4,168)$35,528$38,388$781$(3,143)$36,027

2023 3Q FORM 10-Q 25

The amortized cost of debt securities excludes accrued interest of $493 million and $457 million at September 30, 2023 and December 31, 2022, respectively, which is reported in All other current assets.

The estimated fair value of investment securities at September 30, 2023 decreased since December 31, 2022, primarily due to AerCap, GE HealthCare and Baker Hughes share sales and higher market yields, partially offset by the classification of our remaining equity interest in GE HealthCare within investment securities, the mark-to-market effect on our equity interests in GE HealthCare and AerCap, and new investments at Insurance.

Total estimated fair value of debt securities in an unrealized loss position were $25,932 million and $21,482 million, of which $15,886 million and $3,275 million had gross unrealized losses of $(3,656) million and $(835) million and had been in a loss position for 12 months or more at September 30, 2023 and December 31, 2022, respectively. At September 30, 2023, the majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology and energy industries. In addition, gross unrealized losses on our Mortgage and asset-backed securities included $(224) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(112) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not likely that we will be required to sell the investments before recovery of their amortized cost basis.

Three months ended September 30Nine months ended September 30
2023202220232022
Net unrealized gains (losses) for equity securities with RDFV$(911)$(136)$5,651$(1,970)
Proceeds from debt/equity securities sales and early redemptions3,33669310,0886,115
Gross realized gains on debt securities714434
Gross realized losses and impairments on debt securities(14)(14)(60)(29)

Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at September 30, 2023 are as follows:

Amortized costEstimated fair value
Within one year$859$847
After one year through five years4,8674,793
After five years through ten years5,2115,038
After ten years23,31920,077

We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.

The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $6,434 million and $6,421 million are classified within Level 3, as significant inputs to their valuation models are unobservable at September 30, 2023 and December 31, 2022, respectively. During the nine months ended September 30, 2023 and 2022, there were no significant transfers into or out of Level 3.

In addition to the equity securities described above, we hold $909 million and $614 million of equity securities without RDFV at September 30, 2023 and December 31, 2022, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were immaterial for all periods presented. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy.

NOTE 4. CURRENT AND LONG-TERM RECEIVABLES

CURRENT RECEIVABLESSeptember 30, 2023December 31, 2022
Customer receivables$11,655$11,803
Revenue sharing program receivables(a)1,2651,326
Non-income based tax receivables1,0681,146
Supplier advances833691
Receivables from disposed businesses171115
Other sundry receivables313518
Allowance for credit losses(b)(760)(768)
Total current receivables$14,546$14,831

(a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties.

(b) Allowance for credit losses decreased primarily due to write-offs of $35 million, partially offset by net new provisions of $28 million.

2023 3Q FORM 10-Q 26

September 30, 2023December 31, 2022
Aerospace$7,892$7,784
Renewable Energy2,3442,415
Power4,0024,229
Corporate308404
Total current receivables$14,546$14,831

Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $1,623 million and $1,347 million in the nine months ended September 30, 2023 and 2022, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. Included in the sales of customer receivables in the nine months ended September 30, 2023, was $82 million in our Gas Power business, primarily for risk mitigation purposes.

LONG-TERM RECEIVABLESSeptember 30, 2023December 31, 2022
Long-term customer receivables(a)$483$457
Supplier advances252266
Non-income based tax receivables248213
Sundry receivables578483
Allowance for credit losses(170)(183)
Total long-term receivables$1,391$1,236

(a) The Company sold $83 million of long-term customer receivables to third parties for the nine months ended September 30, 2022, primarily in our Gas Power business for risk mitigation purposes.

NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS

September 30, 2023December 31, 2022
Raw materials and work in process$10,733$9,191
Finished goods4,1403,937
Deferred inventory costs(a)2,1461,764
Inventories, including deferred inventory costs$17,020$14,891

(a) Represents cost deferral for shipped goods (such as components for wind turbine assemblies within our Renewable Energy segment) and labor and overhead costs on time and material service contracts (primarily originating in Power and Aerospace) and other costs for which the criteria for revenue recognition has not yet been met.

NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES

September 30, 2023December 31, 2022
Original cost$27,154$26,641
Less: accumulated depreciation and amortization(16,767)(16,303)
Right-of-use operating lease assets1,8161,854
Property, plant and equipment – net$12,203$12,192

Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities in our Statement of Financial Position, were $1,967 million and $2,089 million, as of September 30, 2023 and December 31, 2022, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $201 million and $205 million, and $602 million and $641 million, for the three and nine months ended September 30, 2023 and 2022, respectively.

NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILLJanuary 1, 2023AcquisitionsCurrency exchange and otherBalance at September 30, 2023
Aerospace$8,835$—$(9)$8,826
Renewable Energy3,201—63,207
Power144160(1)303
Corporate(a)81822(1)839
Total$12,999$182$(5)$13,177

(a) Corporate balance comprises our Digital business.

2023 3Q FORM 10-Q 27

We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the third quarter of 2023, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Digital reporting unit at Corporate and our Additive reporting unit in our Aerospace segment as the fair value of these reporting units were not significantly in excess of their carrying values based on the results of our most recent annual impairment test, performed in the fourth quarter of 2022. At September 30, 2023, our Digital and Additive reporting units had goodwill of $839 million and $238 million, respectively.

Intangible assets decreased $315 million during the nine months ended September 30, 2023, primarily as a result of amortization, partially offset by additions of capitalized software, customer-related and patents and technology, mainly at Power and Aerospace, of $180 million. Consolidated amortization expense was $149 million and $135 million and $448 million and $1,193 million in the three and nine months ended, September 30, 2023 and 2022, respectively. Included within consolidated amortization expense for the nine months ended September 30, 2022 was a non-cash pre-tax impairment charge of $765 million related to intangible assets at our remaining Steam business within our Power segment, not including a related $59 million impairment charge in Property, plant and equipment. For further information on these non-cash pre-tax impairment charges, refer to the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

NOTE 8. REVENUES

EQUIPMENT & SERVICES REVENUES
Three months ended September 3020232022
EquipmentServicesTotalEquipmentServicesTotal
Aerospace$2,299$6,111$8,409$1,968$4,736$6,705
Renewable Energy3,5545974,1512,8877073,594
Power1,2512,7223,9749542,5753,529
Total segment revenues$7,104$9,430$16,533$5,809$8,018$13,828
Nine months ended September 3020232022
EquipmentServicesTotalEquipmentServicesTotal
Aerospace$6,806$16,445$23,250$5,379$13,055$18,434
Renewable Energy9,0841,75410,8377,5052,0599,564
Power3,4268,51911,9453,1168,11711,233
Total segment revenues$19,316$26,717$46,032$16,000$23,231$39,231
REVENUESThree months ended September 30Nine months ended September 30
2023202220232022
Commercial Engines & Services$6,399$4,971$17,293$13,130
Defense1,1111,0273,4703,159
Systems & Other9007072,4872,146
Aerospace$8,409$6,705$23,250$18,434
Onshore Wind$2,431$2,445$6,249$6,403
Grid Solutions equipment and services9467442,6932,145
Offshore Wind, Hydro and Hybrid Solutions7734051,8951,016
Renewable Energy$4,151$3,594$10,837$9,564
Gas Power$2,952$2,612$8,872$8,234
Steam Power5715711,7621,898
Power Conversion, Nuclear and other4503461,3111,101
Power$3,974$3,529$11,945$11,233
Total segment revenues$16,533$13,828$46,032$39,231
GE Digital revenues$226$210$696$635
Insurance revenues8426452,4802,175
Eliminations and other(256)(211)(678)(768)
Corporate$812$643$2,498$2,041
Total revenues$17,346$14,470$48,531$41,272

REMAINING PERFORMANCE OBLIGATION. As of September 30, 2023, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $253,092 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: (1) equipment-related remaining performance obligation of $53,285 million, of which 44%, 69% and 97% is expected to be satisfied within 1, 2 and 5 years, respectively; and (2) services-related remaining performance obligation of $199,807 million, of which 12%, 43%, 67% and 82% is expected to be recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter.

2023 3Q FORM 10-Q 28

NOTE 9. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME

Contract and other deferred assets decreased $942 million in the nine months ended September 30, 2023 primarily due to a decrease in long-term service agreements, partially offset by the timing of revenue recognition ahead of billing milestones on long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $9,577 million, partially offset by revenues recognized of $8,242 million and a net favorable change in estimated profitability of $88 million at Power and $50 million at Aerospace.

September 30, 2023AerospaceRenewable EnergyPowerCorporateTotal
Revenues in excess of billings$2,565$—$5,353$—$7,919
Billings in excess of revenues(7,775)—(1,847)—(9,622)
Long-term service agreements$(5,210)$—$3,506$—$(1,703)
Equipment and other service agreements5211,1811,6142623,578
Current contract assets$(4,689)$1,181$5,120$262$1,875
Nonrecurring engineering costs(a)2,449192—2,470
Customer advances and other(b)2,344—613—2,957
Non-current contract and other deferred assets$4,793$19$615$—$5,427
Total contract and other deferred assets$104$1,200$5,735$262$7,302
December 31, 2022
Revenues in excess of billings$2,363$—$5,403$—$7,766
Billings in excess of revenues(6,681)—(1,763)—(8,443)
Long-term service agreements$(4,318)$—$3,640$—$(677)
Equipment and other service agreements4331,0631,4042453,144
Current contract assets$(3,884)$1,063$5,044$245$2,467
Nonrecurring engineering costs(a)2,513174—2,534
Customer advances and other(b)2,519—724—3,243
Non-current contract and other deferred assets$5,032$17$728$—$5,776
Total contract and other deferred assets$1,148$1,079$5,772$245$8,244

(a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced.

(b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements.

Progress collections and deferred income increased $897 million primarily due to new collections received in excess of revenue recognition primarily at Power, partially offset by net liquidations at Renewable Energy. Revenues recognized for contracts included in a liability position at the beginning of the year were $11,421 million and $10,044 million for the nine months ended September 30, 2023 and 2022, respectively.

September 30, 2023AerospaceRenewable EnergyPowerCorporateTotal
Progress collections$5,917$4,939$5,750$103$16,708
Current deferred income1941746102476
Progress collections and deferred income$6,111$5,113$5,756$205$17,185
Non-current deferred income1,10917736151,337
Total Progress collections and deferred income$7,220$5,290$5,792$220$18,522
December 31, 2022
Progress collections$5,814$5,195$4,514$131$15,655
Current deferred income23320813107562
Progress collections and deferred income$6,047$5,404$4,527$238$16,216
Non-current deferred income1,110183104121,409
Total Progress collections and deferred income$7,157$5,586$4,632$250$17,625

NOTE 10. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method and other investments, long-term customer and sundry receivables (see Note 4), cash and cash equivalents and receivables in our run-off insurance operations and prepaid taxes and other deferred charges. All other non-current assets increased $831 million in the nine months ended September 30, 2023, primarily due to an increase in equity method and other investments of $478 million, an increase in long-term receivables of $155 million, an increase in pension surplus of $101 million and an increase in Insurance cash and cash equivalents of $98 million. Insurance cash and cash equivalents was $717 million and $619 million at September 30, 2023 and December 31, 2022, respectively.

2023 3Q FORM 10-Q 29

NOTE 11. BORROWINGS

September 30, 2023December 31, 2022
Current portion of long-term borrowings
Senior notes issued by GE$192$464
Senior and subordinated notes assumed by GE9151,973
Senior notes issued by GE Capital1061,188
Other121115
Total short-term borrowings$1,334$3,739
Senior notes issued by GE$4,587$4,724
Senior and subordinated notes assumed by GE8,4738,406
Senior notes issued by GE Capital5,6206,289
Other809901
Total long-term borrowings$19,488$20,320
Total borrowings$20,822$24,059

The Company has provided a full and unconditional guarantee on the payment of the principal and interest on all senior and subordinated outstanding long-term debt securities issued by subsidiaries of GE Capital, our former financial services business. See Note 21 for further information about borrowings and associated hedges.

NOTE 12. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES

September 30, 2023December 31, 2022
Trade payables$10,693$10,033
Supply chain finance programs3,6053,689
Equipment project payables(a)1,1221,236
Non-income based tax payables365441
Accounts payable and equipment project payables$15,785$15,399

(a) Primarily related to projects in our Power and Renewable Energy segments.

We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $6,044 million and $5,180 million for the nine months ended September 30, 2023 and 2022, respectively.

NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. On January 1, 2023, we adopted Accounting Standards Update No. 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The new guidance for measuring the liability for future policy benefits and related reinsurance recoverable asset was adopted on a modified retrospective basis such that those balances were adjusted to conform to the new guidance at the January 1, 2021 transition date. Refer to the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023 for more information.

Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $842 million and $645 million, profit was $99 million and $102 million and net earnings was $77 million and $78 million for the three months ended September 30, 2023 and 2022, respectively. For the nine months ended September 30, 2023 and 2022, revenues were $2,480 million and $2,175 million, profit was $233 million and $264 million and net earnings was $181 million and $208 million, respectively. These operations were supported by assets of $45,420 million and $45,031 million at September 30, 2023 and December 31, 2022, respectively. A summary of our insurance liabilities and annuity benefits is presented below:

September 30, 2023Long-term careStructured settlement annuitiesLifeOther contractsTotal
Future policy benefit reserves$23,801$8,534$1,040$405$33,780
Investment contracts—812—7821,594
Other——172286458
Total$23,801$9,346$1,212$1,473$35,832
December 31, 2022
Future policy benefit reserves$24,256$8,860$1,040$437$34,593
Investment contracts—860—8491,708
Other——178365544
Total$24,256$9,720$1,218$1,651$36,845

2023 3Q FORM 10-Q 30

The following tables summarize balances of and changes in future policy benefits reserves.

September 30, 2023September 30, 2022
Present value of expected net premiumsLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Balance, beginning of year$4,059$—$4,828$5,652$—$6,622
Beginning balance at locked-in discount rate3,958—5,2104,451—5,443
Effect of changes in cash flow assumptions(9)—(77)(3)—91
Effect of actual variances from expected experience(42)—(286)(259)—(14)
Adjusted beginning of year balance3,908—4,8474,189—5,520
Interest accrual157—148170—153
Net premiums collected(296)—(220)(321)—(252)
Effect of foreign currency——11——(209)
Ending balance at locked-in discount rate3,768—4,7864,038—5,212
Effect of changes in discount rate assumptions43—(500)32—(410)
Balance, end of period$3,811$—$4,286$4,070$—$4,802
Present value of expected future policy benefits
Balance, beginning of year$28,316$8,860$5,868$40,296$12,328$7,923
Beginning balance at locked-in discount rate27,0268,7906,24727,4659,0246,560
Effect of changes in cash flow assumptions(41)(16)49(392)(23)120
Effect of actual variances from expected experience(79)18(254)(344)(3)9
Adjusted beginning of year balance26,9068,7926,04226,7298,9986,689
Interest accrual1,0913421771,089355184
Benefit payments(947)(511)(396)(855)(510)(399)
Effect of foreign currency——12——(220)
Ending balance at locked-in discount rate27,0508,6235,83526,9628,8436,254
Effect of changes in discount rate assumptions562(89)(509)610(81)(417)
Balance, end of period$27,612$8,534$5,326$27,572$8,762$5,837
Net future policy benefit reserves$23,801$8,534$1,040$23,503$8,762$1,035
Less: Reinsurance recoverables, net of allowance for credit losses(133)—(39)(2,869)—(66)
Net future policy benefit reserves, after reinsurance recoverables$23,668$8,534$1,001$20,634$8,762$969

The Statement of Earnings (Loss) for the nine months ended September 30, 2023 and 2022 included gross premiums or assessments of $636 million and $685 million and interest accretion of $1,305 million and $1,304 million, respectively. For the nine months ended September 30, 2023 and 2022, gross premiums or assessments were substantially all related to long-term care of $367 million and $365 million and life of $251 million and $297 million, while interest accretion was substantially all related to long-term care of $934 million and $919 million and structured settlement annuities of $342 million and $355 million, respectively.

The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses.

September 30, 2023September 30, 2022
UndiscountedDiscounted(a)UndiscountedDiscounted(a)
Long-term care:Gross premiums$7,522$4,656$8,057$4,858
Benefit payments63,40627,61265,62027,572
Structured settlement annuities:Benefit payments19,4808,53420,1228,762
Life:Gross premiums12,3875,14413,7865,905
Benefit payments11,2145,32612,0235,837

(a) Determined using the current discount rate as of September 30, 2023 and 2022.

2023 3Q FORM 10-Q 31

The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits.

September 30, 2023September 30, 2022
Long-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Duration (years)(a)12.310.55.313.010.75.1
Interest accretion rate5.5%5.4%4.9%5.5%5.4%4.9%
Current discount rate5.8%5.7%5.6%5.7%5.7%5.5%

(a) Determined using the current discount rate as of September 30 2023 and 2022.

Our 2023 annual review of future policy benefit reserves cash flow assumptions resulted in an immaterial charge to net earnings, indicating claims experience continues to develop consistently with our models. Our 2022 annual review resulted in changes to our assumptions principally related to higher near-term mortality related to COVID-19.

Included in Insurance losses and annuity benefits in our Statement of Earnings (Loss) for the nine months ended September 30, 2023 and 2022 are unfavorable and favorable pre-tax adjustments of $90 million and $448 million, respectively, from updating the net premium ratio (i.e., the percentage of projected gross premiums required to cover expected policy benefits and related expenses) after updating for actual historical experience each quarter and updating of future cash flow assumptions. Included in these amounts for the nine months ended September 30, 2023 and 2022, are unfavorable adjustments of $298 million and $112 million, respectively, due to insufficient gross premiums (i.e., net premium ratio exceeded 100%), related to certain cohorts in our long-term care and life insurance portfolios. These adjustments are primarily attributable to increases in the net premium ratio as a result of updating future cash flow assumptions on cohorts where the beginning of the period net premium ratio exceeded 100%.

At September 30, 2023 and 2022, policyholders account balances totaled $1,838 million and $2,008 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the nine months ended September 30, 2023 and 2022 are primarily attributed to surrenders, withdrawals, and benefit payments of $318 million and $334 million, partially offset by net additions from separate accounts and interest credited of $188 million and $210 million, respectively. Interest on policyholder account balances is generally credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both September 30, 2023 and 2022.

See Note 3 for further information related to our run-off insurance operations.

NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements in the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023, for further information.

The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss).

PRINCIPAL PENSION PLANSThree months ended September 30Nine months ended September 30
2023202220232022
Service cost for benefits earned$23$48$68$146
Expected return on plan assets(594)(785)(1,782)(2,356)
Interest cost on benefit obligations4735181,4191,551
Net actuarial loss amortization and other(180)356(539)1,071
Net periodic expense (income)(278)137(834)412
Less discontinued operations—48—143
Continuing operations – net periodic expense (income)$(278)$89$(834)$269

Principal retiree benefit plans income was $37 million and $53 million for the three months ended September 30, 2023 and 2022, respectively, and $109 million and $158 million for the nine months ended September 30, 2023 and 2022, respectively. Principal retiree benefit plans income from continuing operations was $34 million and $101 million for the three months and nine months ended September 30, 2022, respectively. Other pension plans income was $32 million and $94 million for the three months ended September 30, 2023 and 2022, respectively, and $91 million and $310 million for the nine months ended September 30, 2023 and 2022, respectively. Other pension plans income from continuing operations was $68 million and $229 million for the three months and nine months ended September 30, 2022, respectively.

We also have a defined contribution plan for eligible U.S. employees that provides employer contributions which were $73 million and $109 million for the three months ended September 30, 2023 and 2022, respectively, and $253 million and $333 million for the nine months ended September 30, 2023 and 2022, respectively. Employer contributions from continuing operations were $78 million and $236 million for the three months and nine months ended September 30, 2022, respectively.

2023 3Q FORM 10-Q 32

NOTE 15. CURRENT AND ALL OTHER LIABILITIES. All other current liabilities and All other liabilities primarily include liabilities for customer sales allowances, equipment project and commercial liabilities, loss contracts, employee compensation and benefits, income taxes payable and uncertain tax positions, operating lease liabilities (see Note 6), environmental, health and safety remediations and product warranties (see Note 23). All other current liabilities decreased $104 million in the nine months ended September 30, 2023, primarily due to decreases in sales discounts and allowances of $147 million, environmental, health and safety liabilities of $95 million, interest payable of $92 million and derivative instruments of $77 million, partially offset by an increase in equipment projects and other commercial liabilities of $257 million. All other liabilities increased $115 million in the nine months ended September 30, 2023, primarily due to increases in uncertain and other income taxes and related liabilities of $395 million and environmental, health and safety liabilities of $103 million, partially offset by decreases in equipment projects and other commercial liabilities of $198 million and operating lease liabilities of $122 million.

NOTE 16. INCOME TAXES. Our income tax rate was 9.1% and (8.5)% for the nine months ended September 30, 2023 and 2022, respectively. The low tax rate for 2023 was primarily due to the unrealized gain on our investment in GE HealthCare, which we expect to recover in a manner consistent with the tax-free treatment confirmed in our Internal Revenue Service (IRS) ruling in connection with the spin of GE Healthcare, U.S. general business credits and net tax benefit related to separation income tax effects including losses on Separation-related entity restructuring. This was partially offset by losses in foreign jurisdictions that are not likely to be utilized. The tax rate for 2022 reflects a tax provision on a pre-tax loss. The rate was negative primarily due to the net unrealized capital loss on our retained and sold ownership interests for which the loss could not be tax benefited, losses in foreign jurisdictions that are not likely to be utilized and non-tax benefited asset impairment charges.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act that includes a new Corporate Alternative Minimum Tax (CAMT) based upon financial statement income, an excise tax on stock buybacks and tax incentives for energy and climate initiatives, among other provisions. The new CAMT is expected to slow but not eliminate the favorable tax impact of our deferred tax assets, resulting in higher cash tax in some years that would generate future tax benefits. The impact of CAMT will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury. We currently do not expect to incur CAMT in 2023.

The IRS is currently auditing our consolidated U.S. income tax returns for 2016-2018.

NOTE 17. SHAREHOLDERS’ EQUITY

Three months ended September 30Nine months ended September 30
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) (Dividends per share in dollars)2023202220232022
Beginning balance$(3,409)$(5,512)$(5,893)$(4,569)
AOCI before reclasses – net of taxes of $141, $79, $123 and $215(396)(874)(176)(1,815)
Reclasses from AOCI – net of taxes of $0, $0, $(626) and $0(a)——2,262—
AOCI(396)(874)2,085(1,815)
Less AOCI attributable to noncontrolling interests1(4)(1)(2)
Currency translation adjustments AOCI$(3,806)$(6,382)$(3,806)$(6,382)
Beginning balance$4,041$4,173$6,531$3,646
AOCI before reclasses – net of taxes of $10, $24, $9 and $811966(24)217
Reclasses from AOCI – net of taxes of $(61), $53, $(718) and $159(a)(207)193(2,656)571
AOCI(188)259(2,680)788
Less AOCI attributable to noncontrolling interests——(2)2
Benefit plans AOCI$3,853$4,432$3,853$4,432
Beginning balance$(1,696)$(521)$(1,927)$5,172
AOCI before reclasses – net of taxes of $(371), $(494), $(310) and $(2,015)(1,370)(1,894)(1,099)(7,601)
Reclasses from AOCI – net of taxes of $(2), $3, $(5) and $10(a)(8)(10)(49)4
AOCI(1,379)(1,904)(1,147)(7,597)
Investment securities and cash flow hedges AOCI$(3,075)$(2,425)$(3,075)$(2,425)
Beginning balance$(2,510)$(2,196)$(983)$(9,109)
AOCI before reclasses – net of taxes of $581, $542, $175 and $2,3792,1872,0366608,949
AOCI2,1872,0366608,949
Long-duration insurance contracts AOCI$(323)$(160)$(323)$(160)
AOCI at September 30$(3,351)$(4,536)$(3,351)$(4,536)
Dividends declared per common share$0.08$0.08$0.24$0.24

(a)The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in first quarter of 2023 related to the spin-off of GE HealthCare.

2023 3Q FORM 10-Q 33

Preferred stock. On September 15, 2023 we redeemed the remaining outstanding shares of GE preferred stock. We redeemed $2,795 million and $5,795 million of GE preferred stock in the three months and nine months ended September 30, 2023. GE preferred shares outstanding was 5,795,444 at December 31, 2022.

Common stock. GE common stock shares outstanding were 1,088,386,043 and 1,089,107,878 at September 30, 2023 and December 31, 2022, respectively. For further information on our common and preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

NOTE 18. EARNINGS PER SHARE INFORMATION

Three months ended September 3020232022
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasic
Earnings (loss) from continuing operations$175$175$(243)$(243)
Preferred stock dividends and other and accretion of preferred share repurchase(a)(91)(91)(70)(70)
Earnings (loss) from continuing operations attributable to common shareholders8484(313)(313)
Earnings (loss) from discontinued operations173173403403
Net earnings (loss) attributable to GE common shareholders2582589191
Shares of GE common stock outstanding1,0881,0881,0951,095
Employee compensation-related shares (including stock options)11———
Total average equivalent shares1,0991,0881,0951,095
Earnings (loss) per share from continuing operations$0.08$0.08$(0.29)$(0.29)
Earnings (loss) per share from discontinued operations0.160.160.370.37
Net earnings (loss) per share0.230.240.080.08
Potentially dilutive securities(b)2149
Nine months ended September 3020232022
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasic
Earnings (loss) from continuing operations$7,474$7,477$(2,600)$(2,600)
Preferred stock dividends and other and accretion of preferred share repurchase(a)(295)(295)(189)(189)
Earnings (loss) from continuing operations attributable to common shareholders7,1807,183(2,789)(2,789)
Earnings (loss) from discontinued operations411411743743
Net earnings (loss) attributable to GE common shareholders7,5917,594(2,046)(2,046)
Shares of GE common stock outstanding1,0891,0891,0971,097
Employee compensation-related shares (including stock options)9———
Total average equivalent shares1,0981,0891,0971,097
Earnings (loss) per share from continuing operations$6.54$6.60$(2.54)$(2.54)
Earnings (loss) per share from discontinued operations0.370.380.680.68
Net earnings (loss) per share6.916.98(1.86)(1.86)
Potentially dilutive securities(b)2946

(a) For the three and nine months ended September 30, 2023, included $(28) million and $(58) million related to excise tax on preferred share redemptions, respectively.

(b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three and nine months ended September 30, 2023, application of this treatment had an insignificant effect. For the three and nine months ended September 30, 2022, as a result of the loss from continuing operations, losses were not allocated to the participating securities.

2023 3Q FORM 10-Q 34

NOTE 19. OTHER INCOME (LOSS)

Three months ended September 30Nine months ended September 30
2023202220232022
Investment in GE HealthCare realized and unrealized gain (loss)$(813)$—$5,066$—
Investment in and note with AerCap realized and unrealized gain (loss)(296)13881(2,669)
Investment in Baker Hughes realized and unrealized gain (loss)—(238)10818
Gains (losses) on retained and sold ownership interests$(1,109)$(101)$5,157$(1,852)
Other net interest and investment income (loss)193123534269
Licensing and royalty income5354178141
Equity method income7814147129
Purchases and sales of business interests(a)1152310342
Other items(2)65(18)270
Total other income (loss)$(673)$178$6,100$(1,000)

(a) Included a pre-tax gain of $90 million related to the sale of an investment at Energy Financial Services during the three months ended September 30, 2023.

Our investment in GE HealthCare comprises 61.6 million shares (approximately 13.5% ownership interest) at September 30, 2023. During the nine months ended September 30, 2023, we received total proceeds of $2,192 million from the disposition of GE HealthCare shares. Our investment in AerCap comprises 30.9 million ordinary shares (approximately 14.5% ownership interest) at September 30, 2023 and an AerCap senior note. During the nine months ended September 30, 2023, we received total proceeds of $4,624 million from the sale of AerCap shares. During the first quarter of 2023, we received proceeds of $216 million from the sale of Baker Hughes shares and have now fully monetized our position.

NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS

RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate.

Three months ended September 30Nine months ended September 30
RESTRUCTURING AND OTHER CHARGES2023202220232022
Workforce reductions$70$51$227$70
Plant closures & associated costs and other asset write-downs624818398
Acquisition/disposition net charges and other21144839
Total restructuring and other charges$153$112$458$206
Cost of equipment/services$51$66$116$109
Selling, general and administrative expenses10246342100
Other (income) loss———(3)
Total restructuring and other charges$153$112$458$206
Aerospace$3$6$10$16
Renewable Energy576619878
Power43308197
Corporate501016915
Total restructuring and other charges$153$112$458$206
Restructuring and other charges cash expenditures$89$75$382$286

An analysis of changes in the liability for restructuring follows:

Three months ended September 30Nine months ended September 30
2023202220232022
Balance at beginning of period$963$640$977$825
Additions6796238127
Payments(75)(54)(259)(242)
Effect of foreign currency and other(69)(17)(71)(45)
Balance at September 30(a)$885$665$885$665

(a) Includes actuarial determined post-employment severance benefits reserve of $367 million and $333 million as of September 30, 2023 and 2022, respectively.

2023 3Q FORM 10-Q 35

For the three and nine months ended September 30, 2023, restructuring and other initiatives primarily included exit activities related to the restructuring programs announced in 2022, reflecting lower Corporate shared-service and footprint needs as a result of the GE HealthCare spin-off, and exit activities across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. This plan was expanded during the third quarter of 2023 to include the consolidation of the global footprint and related resources at our Power business to better serve our customers. We recorded total charges of $153 million and $458 million, consisting of $86 million and $220 million, primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $67 million and $238 million primarily in employee workforce reduction charges, which are reflected in the table above in the three and nine months ended September 30, 2023, respectively. We incurred $89 million and $382 million in cash outflows related to restructuring actions, primarily for employee severance payments and contract terminations in the three and nine months ended September 30, 2023, respectively.

For the three months ended September 30, 2022, restructuring and other initiatives primarily included exit activities across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. For the nine months ended September 30, 2022, restructuring and other initiatives primarily included exit activities at our Power business related to our new coal build wind-down actions which included the exit of certain product lines, closing certain manufacturing and office facilities, and workforce reduction programs. We recorded total charges of $112 million and $206 million, consisting of $16 million and $79 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $96 million and $127 million primarily in employee workforce reduction charges, which are reflected in the table above in the three and nine months ended September 30, 2022, respectively. We incurred $75 million and $286 million in cash outflows related to restructuring actions, primarily for employee severance payments in the three and nine months ended September 30, 2022, respectively.

SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we have incurred and expect to continue to incur separation, transition, and operational costs, which will depend on specifics of the transactions.

For the three and nine months ended September 30, 2023, we incurred pre-tax separation expense of $227 million and $658 million, and paid $175 million and $751 million in cash, respectively, primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to three stand-alone public companies. These costs are presented as separation costs in our consolidated Statement of Earnings (Loss). In addition, we recognized $278 million and $256 million of net tax benefit, including a net tax benefit associated with planned legal entity separation and tax on changes to indefinite reinvestment of foreign earnings in the three and nine months ended September 30, 2023, respectively.

For the three and nine months ended September 30, 2022, we incurred pre-tax separation costs of $171 million and $419 million, and paid $60 million and $72 million in cash, and recognized $32 million and $24 million of net tax benefit, respectively, related to separation activities.

As discussed in Note 2, GE completed the separation of its HealthCare business into a separate, independent publicly traded company, GE HealthCare Technologies Inc. As a result, pre-tax separation costs specifically identifiable to GE HealthCare are now reflected in discontinued operations. We incurred $2 million and $22 million in pre-tax costs for the three and nine months ended September 30, 2023, respectively, recognized $5 million of tax benefits for the nine months ended September 30, 2023, and spent $27 million and $167 million in cash for the three and nine months ended September 30, 2023, respectively.

NOTE 21. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2.

September 30, 2023December 31, 2022
Carrying amount (net)Estimated fair valueCarrying amount (net)Estimated fair value
AssetsLoans and other receivables$2,378$2,203$2,557$2,418
LiabilitiesBorrowings (Note 11)$20,822$19,361$24,059$22,849
Investment contracts (Note 13)1,5941,5981,7081,758

Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments.

DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices.

2023 3Q FORM 10-Q 36

FAIR VALUE OF DERIVATIVESSeptember 30, 2023December 31, 2022
Gross NotionalAll other current assetsAll other current liabilitiesGross NotionalAll other current assetsAll other current liabilities
Qualifying currency exchange contracts$6,510$142$116$5,112$132$146
Non-qualifying currency exchange contracts and other56,58690494552,7861,1431,095
Gross derivatives$63,096$1,047$1,061$57,898$1,275$1,241
Netting and credit adjustments$(719)$(718)$(821)$(820)
Net derivatives in statement of financial position$327$343$454$420

FAIR VALUE HEDGES. As of September 30, 2023, all fair value hedges were terminated due to exposure management actions, including debt maturities. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the hedged borrowings mature. The cumulative amount of hedging adjustments of $1,165 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,715 million. At September 30, 2022, the cumulative amount of hedging adjustments of $1,693 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $13,825 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings.

CASH FLOW HEDGES AND NET INVESTMENT HEDGES
Gain (loss) recognized in AOCIThree months ended September 30Nine months ended September 30
2023202220232022
Cash flow hedges(a)$(7)$(95)$42$(252)
Net investment hedges(b)17139641691

(a) Primarily related to currency exchange contracts.

(b) The carrying value of foreign currency debt designated as net investment hedges was $4,554 million and $3,019 million as of September 30, 2023 and 2022, respectively. The total reclassified from AOCI into earnings was zero for both the three months and nine months ended September 30, 2023 and 2022.

Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $24 million loss as of September 30, 2023. We expect to reclassify $68 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. As of September 30, 2023, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years.

The table below presents the effects of hedges and resulting gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss):

Three months ended September 30, 2023Three months ended September 30, 2022
RevenuesInterest ExpenseSG&AOther(a)RevenuesInterest ExpenseSG&AOther(a)
$17,346$286$2,171$12,232$14,470$374$1,966$11,712
Cash flow hedges$(14)$(2)$1$17$(3)$(4)$(1)$(12)
Non-hedging derivatives (b)$—$—$(295)$(18)$1$—$33$(447)
Nine months ended September 30, 2023Nine months ended September 30, 2022
RevenuesInterest ExpenseSG&AOther(a)RevenuesInterest ExpenseSG&AOther(a)
$48,531$822$6,671$42,096$41,272$1,130$6,509$30,832
Cash flow hedges$(9)$(8)$1$25$1$(17)$(1)$(80)
Fair value hedges$(16)
Non-hedging derivatives (b)$—$—$(5)$(145)$3$—$(421)$(542)

(a) Amounts are inclusive of cost of sales and other income (loss).

(b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities.

COUNTERPARTY CREDIT RISK. Our exposures to counterparties were $256 million and $306 million at September 30, 2023 and December 31, 2022, respectively. Counterparties' exposures to our derivative liability were $294 million and $365 million at September 30, 2023 and December 31, 2022, respectively.

2023 3Q FORM 10-Q 37

NOTE 22. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $114 million and $401 million and liabilities of $198 million and $206 million at September 30, 2023 and December 31, 2022, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

Our investments in unconsolidated VIEs were $6,388 million and $5,917 million at September 30, 2023 and December 31, 2022, respectively. Of these investments, $1,302 million and $1,481 million were owned by EFS, comprising equity method investments, primarily renewable energy tax equity investments, at September 30, 2023 and December 31, 2022, respectively. In addition, $4,855 million and $4,219 million were owned by our run-off insurance operations, primarily comprising equity method investments at September 30, 2023 and December 31, 2022, respectively. Our maximum exposure to loss in respect of unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 23.

NOTE 23. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES

COMMITMENTS. We had total investment commitments of $3,886 million at September 30, 2023. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,813 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,709 million. See Note 22 for further information.

As of September 30, 2023, in our Aerospace segment, we have committed to provide financing assistance of $2,670 million of future customer acquisitions of aircraft equipped with our engines.

GUARANTEES. Indemnification agreements - Discontinued Operations. Following the Separation of GE HealthCare on January 3, 2023, GE has remaining performance and bank guarantees on behalf of its former HealthCare business, with a maximum aggregate exposure of $44 million at September 30, 2023. Most of these guarantees are not expected to remain in effect as of December 31, 2023. GE also has obligations under the Transition Services Agreement and Tax Matters Agreement to indemnify GE HealthCare for certain technology and tax costs of $90 million, which are fully reserved. In addition, we have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $703 million with related reserves of $70 million.

Indemnification agreements – Continuing Operations. GE has obligations under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs and other indemnifications of $43 million, which are fully reserved. In addition, we have $554 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $76 million.

For information on credit support agreements, refer to the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,997 million and $1,960 million at September 30, 2023 and December 31, 2022, respectively.

LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 in the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023 and Note 23 in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.

2023 3Q FORM 10-Q 38

Alstom legacy legal matters. In 2015, we acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $416 million and $455 million at September 30, 2023 and December 31, 2022, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided.

Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws have been filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case, also referred to as the Sjunde AP-Fonden case). In October 2019, the lead plaintiff filed a fifth amended consolidated class action complaint naming as defendants GE and current and former GE executive officers. It alleges violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted defendants’ motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018, and granted the plaintiffs’ request to amend their complaint. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims. In September 2023, the court denied GE’s motion for summary judgment, except as to claims arising from disclosures made between November 2017 and January 2018.

In February 2019, a securities action (the Touchstone case) was filed in the U.S. District Court for the Southern District of New York naming as defendants GE and current and former GE executive officers. It alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Section 1707.43 of the Ohio Securities Act and common law fraud based on alleged misstatements regarding insurance reserves, GE Power’s revenue recognition practices related to long term service agreements, GE’s acquisition of Alstom, and the goodwill recognized in connection with that transaction. The lawsuit seeks damages on behalf of six institutional investors who purchased GE common stock between August 1, 2014 and October 30, 2018 and rescission of those purchases. In May 2021, the plaintiffs filed an amended complaint, and GE in June 2021 filed a motion to dismiss that complaint. In September 2022, the court granted GE’s motion to the dismiss the plaintiffs’ case with no opportunity to replead their case. In January 2023, the plaintiffs filed an appeal of the court’s dismissal of their case with the U.S. Court of Appeals for the Second Circuit. In September 2023, the Court of Appeals affirmed the dismissal of the case.

GE Retirement Savings Plan (RSP) class actions. Four putative class action lawsuits were filed regarding the oversight of the GE RSP, and those class actions were consolidated into a single action in the U.S. District Court for the District of Massachusetts. The consolidated complaint named as defendants GE, GE Asset Management, current and former GE and GE Asset Management executive officers and employees who served on fiduciary bodies responsible for aspects of the GE RSP during the class period. Like similar lawsuits that were brought against other companies in recent years, this action alleged that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act (ERISA) in their oversight of the GE RSP, principally by retaining five proprietary funds that plaintiffs allege were underperforming as investment options for plan participants and by charging higher management fees than some alternative funds. The plaintiffs sought unspecified damages on behalf of a class of GE RSP participants and beneficiaries from September 26, 2011 through the date of any judgment. In August and December 2018, the court issued orders dismissing one count of the complaint and denying GE's motion to dismiss the remaining counts. In September 2022, both GE and the plaintiffs filed motions for summary judgment on the remaining claims. In September 2023, GE executed a class action settlement with plaintiffs in the amount of $61 million, which the court preliminarily approved in October 2023. Net of insurance contributions, this had an immaterial financial impact on GE’s results for the quarter ended September 30, 2023.

Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For several years, GE has observed an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded an additional charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH as of September 30, 2023 was $2,522 million. This estimate accounts for the costs of payments to borrowers who we estimate will participate in the settlement program, as well as estimates of litigation with other borrowers where remedies can often exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time. However, there are a number of factors that could affect the estimate in the future; refer to the disclosures about Bank BPH in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 and other prior filings for additional details.

2023 3Q FORM 10-Q 39

ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. As previously reported, in 2000, GE and the Environmental Protection Agency (EPA) entered into a consent decree relating to PCB cleanup of the Housatonic River in Massachusetts. Following the EPA’s release in September 2015 of an intended final remediation decision, GE and the EPA engaged in mediation and the first step of the dispute resolution process contemplated by the consent decree. In October 2016, the EPA issued its final decision pursuant to the consent decree, which GE and several other interested parties appealed to the EPA’s Environmental Appeals Board (EAB). The EAB issued its decision in January 2018, affirming parts of the EPA’s decision and granting relief to GE on certain significant elements of its challenge. The EAB remanded the decision back to the EPA to address those elements and reissue a revised final remedy, and the EPA convened a mediation process with GE and interested stakeholders. In February 2020, the EPA announced an agreement between the EPA and many of the mediation stakeholders, including GE, concerning a revised Housatonic River remedy. Based on the mediated resolution, the EPA solicited public comment on a draft permit and issued the final revised permit effective in January 2021. In March 2021, two local environmental advocacy groups filed a joint petition to the EAB challenging portions of the revised permit; in February 2022, the EAB denied the petition, and the permit became effective in March 2022. In May 2022, the two environmental advocacy groups petitioned the U.S. Court of Appeals for the First Circuit to review the EPA’s final permit, and the Court denied the petition in July 2023. As of September 30, 2023, and based on its assessment of current facts and circumstances and its defenses, GE believes that it has recorded adequate reserves to cover future obligations associated with the proposed final remedy. For further information about environmental, health and safety matters, see the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits